Your browser doesn't support javascript.
loading
EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.
Lindblom, Julius; Gomez, Alvaro; Borg, Alexander; Emamikia, Sharzad; Ladakis, Dimitris; Matilla, Joaquin; Pehr, Martin; Cobar, Flordelyn; Enman, Yvonne; Heintz, Emelie; Regardt, Malin; Parodis, Ioannis.
Afiliação
  • Lindblom J; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Gomez A; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Borg A; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Emamikia S; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Ladakis D; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Matilla J; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Pehr M; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Cobar F; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Enman Y; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Heintz E; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
  • Regardt M; Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet.
  • Parodis I; Department of Gastroenterology, Dermatology and Rheumatology, Karolinska University Hospital.
Rheumatology (Oxford) ; 60(10): 4703-4716, 2021 10 02.
Article em En | MEDLINE | ID: mdl-33502473

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Monitoramento de Medicamentos / Anticorpos Monoclonais Humanizados / Imunossupressores / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação de Resultados em Cuidados de Saúde / Monitoramento de Medicamentos / Anticorpos Monoclonais Humanizados / Imunossupressores / Lúpus Eritematoso Sistêmico Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatology (Oxford) Ano de publicação: 2021 Tipo de documento: Article